212 related articles for article (PubMed ID: 17965187)
1. Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.
Ikuta M; Kornienko M; Byrne N; Reid JC; Mizuarai S; Kotani H; Munshi SK
Protein Sci; 2007 Dec; 16(12):2626-35. PubMed ID: 17965187
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Roux PP; Richards SA; Blenis J
Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the autoinhibition of the C-terminal kinase domain of human RSK1.
Li D; Fu TM; Nan J; Liu C; Li LF; Su XD
Acta Crystallogr D Biol Crystallogr; 2012 Jun; 68(Pt 6):680-5. PubMed ID: 22683790
[TBL] [Abstract][Full Text] [Related]
4. Dynamic control of RSK complexes by phosphoswitch-based regulation.
Gógl G; Biri-Kovács B; Póti ÁL; Vadászi H; Szeder B; Bodor A; Schlosser G; Ács A; Turiák L; Buday L; Alexa A; Nyitray L; Reményi A
FEBS J; 2018 Jan; 285(1):46-71. PubMed ID: 29083550
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK.
Richards SA; Fu J; Romanelli A; Shimamura A; Blenis J
Curr Biol; 1999 Jul 29-Aug 12; 9(15):810-20. PubMed ID: 10469565
[TBL] [Abstract][Full Text] [Related]
6. Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.
Malakhova M; Kurinov I; Liu K; Zheng D; D'Angelo I; Shim JH; Steinman V; Bode AM; Dong Z
PLoS One; 2009 Nov; 4(11):e8044. PubMed ID: 19956600
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY.
Gógl G; Alexa A; Kiss B; Katona G; Kovács M; Bodor A; Reményi A; Nyitray L
J Biol Chem; 2016 Jan; 291(1):11-27. PubMed ID: 26527685
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity.
Cavet ME; Lehoux S; Berk BC
J Biol Chem; 2003 May; 278(20):18376-83. PubMed ID: 12618428
[TBL] [Abstract][Full Text] [Related]
9. The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein.
Smith KJ; Carter PS; Bridges A; Horrocks P; Lewis C; Pettman G; Clarke A; Brown M; Hughes J; Wilkinson M; Bax B; Reith A
Structure; 2004 Jun; 12(6):1067-77. PubMed ID: 15274926
[TBL] [Abstract][Full Text] [Related]
10. RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study.
Mayer AMS; Hall ML; Lach J; Clifford J; Chandrasena K; Canton C; Kontoyianni M; Choo YM; Karan D; Hamann MT
Mar Drugs; 2021 Sep; 19(9):. PubMed ID: 34564169
[TBL] [Abstract][Full Text] [Related]
11. Structural assembly of the signaling competent ERK2-RSK1 heterodimeric protein kinase complex.
Alexa A; Gógl G; Glatz G; Garai Á; Zeke A; Varga J; Dudás E; Jeszenői N; Bodor A; Hetényi C; Reményi A
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2711-6. PubMed ID: 25730857
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
[TBL] [Abstract][Full Text] [Related]
13. p90 ribosomal S6 kinase 1 (RSK1) and the catalytic subunit of protein kinase A (PKA) compete for binding the pseudosubstrate region of PKAR1alpha: role in the regulation of PKA and RSK1 activities.
Gao X; Chaturvedi D; Patel TB
J Biol Chem; 2010 Mar; 285(10):6970-9. PubMed ID: 20048145
[TBL] [Abstract][Full Text] [Related]
14. Identification of RSK substrates using an analog-sensitive kinase approach.
Lizcano-Perret B; Vertommen D; Herinckx G; Calabrese V; Gatto L; Roux PP; Michiels T
J Biol Chem; 2024 Mar; 300(3):105739. PubMed ID: 38342435
[TBL] [Abstract][Full Text] [Related]
15. Protein preparation, crystallization and preliminary X-ray analysis of the C-terminal domain of human RSK1 serine/threonine protein kinase.
Fu TM; Li D; Nan J; Li L; Xue Y; Su XD
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Dec; 63(Pt 12):1026-8. PubMed ID: 18084084
[TBL] [Abstract][Full Text] [Related]
16. Regulation of protein kinase A activity by p90 ribosomal S6 kinase 1.
Gao X; Patel TB
J Biol Chem; 2009 Nov; 284(48):33070-8. PubMed ID: 19808666
[TBL] [Abstract][Full Text] [Related]
17. Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases.
Fruergaard MU; Nielsen CJF; Kjeldsen CR; Iversen L; Andersen JL; Nissen P
Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36806093
[TBL] [Abstract][Full Text] [Related]
18. Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model.
Li S; Zhou Y; Lu W; Zhong Y; Song W; Liu K; Huang J; Zhao Z; Xu Y; Liu X; Li H
J Chem Inf Model; 2011 Nov; 51(11):2939-47. PubMed ID: 21995341
[TBL] [Abstract][Full Text] [Related]
19. Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1.
Richards SA; Dreisbach VC; Murphy LO; Blenis J
Mol Cell Biol; 2001 Nov; 21(21):7470-80. PubMed ID: 11585927
[TBL] [Abstract][Full Text] [Related]
20. MAP Kinase-Mediated Activation of RSK1 and MK2 Substrate Kinases.
Sok P; Gógl G; Kumar GS; Alexa A; Singh N; Kirsch K; Sebő A; Drahos L; Gáspári Z; Peti W; Reményi A
Structure; 2020 Oct; 28(10):1101-1113.e5. PubMed ID: 32649858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]